top of page

The State of New York Cannabis

Cannabis industry insiders waiting for their turn.
Industry insiders await their seat at the table.

The cannabis industry in New York, once viewed as a beacon of progressive drug policy and economic opportunity, has encountered a myriad of challenges that have tempered its growth and tested the robustness of its regulatory framework. The recent administrative suspension of Damian Fagon, the Chief Equity Officer at the Office of Cannabis Management (OCM), is a stark reminder of the governance challenges facing the industry. Allegations of retaliation and selective enforcement surrounding Fagon’s suspension have sparked concerns about the integrity of the regulatory process, highlighting the need for transparency and fairness in how cannabis regulations are enforced.

Despite the ambitious rollout of licenses across the state, with Governor Kathy Hochul announcing over 400 licenses issued, the expected economic boom has not materialized as planned. The industry generated only $150 million in sales and $16.3 million in tax revenue in its first full year, significantly missing projections. This shortfall reflects both the growing pains of a new market and deeper systemic issues, including regulatory delays and market saturation.

The legal landscape too has proven to be a formidable challenge, with a recent New York State Supreme Court decision initially invalidating all adult-use cannabis regulations due to restrictive advertising bans. This decision was later modified to only encompass marketing regulations, but it underscored the fragile legal ground on which the state's cannabis policy stands. The ruling highlighted the tension between fostering a viable commercial market and adhering to strict regulatory standards designed to limit the industry’s public presence.

Moreover, the backlog of license applications has become a critical issue, with thousands of applicants waiting for a resolution. This delay breeds economic uncertainty and dissatisfaction among entrepreneurs eager to enter the market. Accusations of favoritism and mishandling of the application process, where some claims suggest applications are being reviewed out of the prescribed order, exacerbate these tensions. Such controversies undermine trust in the system and suggest the need for a more accountable and transparent process.

In response to these challenges, there have been calls for reforms to make the licensing process more transparent and to ensure that it fairly serves communities disproportionately affected by past drug enforcement policies. The state has made efforts to address these concerns by focusing on social and economic equity applicants, but the effectiveness of these measures remains under scrutiny as stakeholders continue to report frustrations with bureaucratic inefficiencies and perceived inequities in the system.

As New York's cannabis industry continues to evolve amidst challenges, it provides invaluable insights for other regions considering similar paths. The journey has been complex, reflecting the nuanced interplay of regulatory frameworks, market forces, and legal mandates. New York's experiences underscore the necessity for adaptable governance to foster a market that is not only profitable but also equitable and sustainable. Moving forward, New York has the opportunity to lead by example, demonstrating how careful management and responsive policies can shape a thriving, responsible cannabis industry.


  1. Governance and Suspensions: The suspension of Damian Fagon from the OCM has highlighted significant governance issues within New York's cannabis industry. Concerns about transparency and fairness in regulatory enforcement have become more prominent. - Cannabis Law Report

  2. Economic Shortfalls: New York’s cannabis market has struggled to meet revenue expectations, with a significant shortfall in sales and tax income. This has raised questions about market saturation and regulatory impact on industry growth. - WSKG

  3. Legal Challenges: The industry has faced legal hurdles, particularly highlighted by a State Supreme Court decision that challenged the state’s advertising restrictions, reflecting the ongoing tension between regulatory intentions and commercial freedoms. - MJBiz Daily

  4. License Backlog and Allegations: There have been numerous complaints about the backlog in processing licenses and allegations of favoritism in the application process. This has undermined trust and called for a need for more transparency. - Cannabis Business Times

  5. Calls for Reform: There is a growing demand for reforms in the licensing process to address issues of equity and transparency, especially to support communities disproportionately affected by past drug policies. - NY Post

44 views0 comments

Recent Posts

See All


bottom of page